Cartron G, Bachy E, Tilly H, Daguindau N, et al. Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study. J Clin Oncol 2023 Apr 18:JCO2202327. doi: 10.1200/JCO.22.02327.
PMID: 37071836